|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
2.01(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38.65 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
31,636 |
387,836 |
590,546 |
794,601 |
Total Sell Value |
$1,475,158 |
$21,735,076 |
$32,576,849 |
$40,646,784 |
Total People Sold |
3 |
5 |
8 |
10 |
Total Sell Transactions |
4 |
11 |
26 |
62 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Zhou Rong |
EVP, Production Center |
|
2021-05-14 |
4 |
OE |
$14.23 |
$158,238 |
D/D |
11,120 |
107,385 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2021-05-13 |
4 |
S |
$19.58 |
$13,706 |
D/D |
(700) |
96,265 |
|
6% |
|
Zhou Rong |
EVP, Production Center |
|
2021-05-13 |
4 |
OE |
$14.23 |
$9,961 |
D/D |
700 |
96,965 |
|
- |
|
Zasloff Michael A |
Director |
|
2021-05-13 |
4 |
S |
$19.34 |
$499,435 |
D/D |
(25,827) |
41,187 |
|
6% |
|
Zasloff Michael A |
Director |
|
2021-05-13 |
4 |
OE |
$16.43 |
$424,338 |
D/D |
25,827 |
67,014 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2021-05-12 |
4 |
S |
$19.33 |
$88,742 |
D/D |
(4,592) |
56,759 |
|
3% |
|
Prins Richard K |
Director |
|
2021-05-11 |
4 |
S |
$18.90 |
$299,110 |
D/D |
(15,827) |
39,160 |
|
1% |
|
Prins Richard K |
Director |
|
2021-05-11 |
4 |
OE |
$16.43 |
$260,038 |
D/D |
15,827 |
54,987 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2021-05-11 |
4 |
S |
$19.06 |
$190,597 |
D/D |
(10,000) |
61,351 |
|
1% |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2021-05-11 |
4 |
OE |
$11.33 |
$113,300 |
D/D |
10,000 |
71,351 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2021-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
56,892 |
1,488,371 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2021-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
127,209 |
2,320,868 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2021-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
19,344 |
61,351 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2021-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
33,574 |
108,302 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2021-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
21,984 |
96,265 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2021-03-16 |
4 |
D |
$18.44 |
$163,932 |
I/I |
(8,890) |
1,431,479 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2021-03-16 |
4 |
D |
$18.44 |
$465,444 |
D/D |
(25,241) |
2,193,659 |
|
- |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2021-03-16 |
4 |
D |
$18.44 |
$44,809 |
D/D |
(2,430) |
42,007 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2021-03-16 |
4 |
D |
$18.44 |
$117,979 |
D/D |
(6,398) |
74,728 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2021-03-16 |
4 |
D |
$18.44 |
$60,907 |
D/D |
(3,303) |
74,281 |
|
- |
|
Zhou Rong |
EVP, Production Center |
|
2021-03-15 |
4 |
D |
$19.15 |
$31,636 |
D/D |
(1,652) |
77,584 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2021-03-15 |
4 |
D |
$19.15 |
$80,009 |
D/D |
(4,178) |
81 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2021-03-15 |
4 |
AS |
$19.03 |
$80,745 |
D/D |
(4,244) |
85,304 |
|
9% |
|
Liawatidewi Yakob |
EVP Corp Admin Center |
|
2021-03-15 |
4 |
D |
$19.15 |
$29,855 |
D/D |
(1,559) |
44,437 |
|
- |
|
Luo Mary Z. |
COO, Chief Scientist, COB |
|
2021-03-15 |
4 |
D |
$19.15 |
$183,687 |
I/I |
(9,592) |
1,440,369 |
|
- |
|
956 Records found
|
|
Page 12 of 39 |
|
|